IBM likes i2, decides to buy it

IBM has entered into a definitive agreement to acquire i2, a provider of intelligence analytics for crime and fraud prevention, to accelerate its business analytics initiatives and help clients in the public and private sectors address crime, fraud and security threats. Financial terms were not disclosed.

i2, based in Cambridge, England, with U.S. headquarters in McLean, Va., has clients in such sectors as healthcare, banking and defense.

The acquisition will extend IBM's presence in helping clients harness these data through the addition of i2's intelligence analysis capabilities.

i2 will be integrated into IBM's Software Group, IBM, of Armonk, N.Y., stated. The acquisition is anticipated to close in the fourth quarter of 2011, subject to the satisfaction of customary closing conditions and applicable regulatory reviews.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup